Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-031403

Options or other derivatives

  • Director acquired 48,917 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lacey John III · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-30 Grant or award : show line 1 in the form Series D-1 Convertible Preferred Stock +48,917 228,509 D
Loading xslF345X06/ownership.xml…